© Florida Institue for Clinical Research | Privacy Policy
Website by 
High Triglycerides (ARO-APOC3)
MUIR-3 AROAPOC3-3009
The purpose of this study is to evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) to reduce levels in adult participants with hypertriglyceridemia (HTG).
To participate in this study you must:
- Have a diagnosis of hypertriglyceridemia (HTG)
- Have TG levels ≥ 150 mg/dL and ≤ 499 mg/dL
- Have an HbA1C of ≤ 8.5%
- Be on standard lipid-lowering medications